首页|期刊导航|癌症(英文版)|Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma

Implications of vessel co-option in sorafenib-resistant hepatocellular carcinomaOACSCDCSTPCD

Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma

Elizabeth A.Kuczynski;Robert S.Kerbel

Sunnybrook Research Institute, 2075 Bayview Avenue, S-Wing, Room S217, Toronto, 0N M4N 3M5, CanadaSunnybrook Research Institute, 2075 Bayview Avenue, S-Wing, Room S217, Toronto, 0N M4N 3M5, Canada

Vessel co-optionNon-angiogenicResistanceSorafenibHepatocellular carcinoma

Vessel co-optionNon-angiogenicResistanceSorafenibHepatocellular carcinoma

《癌症(英文版)》 2016 (12)

641-644,4

10.1186/s40880-016-0162-7

评论

您当前未登录!去登录点击加载更多...